CHEK2 and infection: Interestingly, inhibition of ATM and Chk2 by targeted small molecules (ATM inhibitor KU55933, Chk2 inhibitor BML-277) significantly abrogated fusion and maturation of viroplasms with progression of infection leading to heavily restricted rotaviral propagation (Figure 4e).